Able Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-19
Closed -$2.5K 397
2023
Q4
$2.5K Buy
+19
New +$2.5K ﹤0.01% 426